2916 visitors from Jan 2013
International collaborative group aiming to create, support and disseminate research in cardiovascular field providing CRF web-based platforms for multicenter studies
Coordinator and creator: Enrico Cerrato; Fabrizio D'Ascenzo
Scientific Board: G.Biondi-Zoccai; J.Escaned; C.Moretti; G.Campo; I.Sheiban; C.Templin; I.Nuñez-Gil;           S.Raposeiras Roubín; W.Wojciech; L.Perl; F.Varbella
Injeneering: D.Gallo; U.Morbiducci
In acute ST-segment elevation myocardial infarction (STEMI), the use of percutaneous
coronary intervention (PCI) to treat the artery responsible for the infarct
improves prognosis, but when there are other lesion than the infact related
one the value of PCI in these arteries (preventive PCI) is unknown. Current
guidelines advise to treat only the culprit lesion, so the aim of the Preventive
Angioplasty in Acute Myocardial Infarction (PRAMI) trial, a single-blind,
randomized study, was to determine whether performing preventive PCI as part
of the primary PCI procedure to treat the infarct related artery would reduce
the combined incidence of death from cardiac causes, nonfatal myocardial infarction,
or refractory angina (primary end-point).
From 2008 through 2013, at five centers in the United Kingdom, they enrolled
465 patients with acute STEMI and after the completion of PCI in the infarct
artery, eligible patients were randomly assigned to undergo no further PCI procedures
or to undergo immediate preventive PCI in noninfarct arteries with more than
50% stenoses (preventive PCI). Subsequent PCI for angina was recommended only
for refractory angina with objective evidence of ischemia. Then an intention-to-treat
analysis was used. During a mean follow-up of 23 months, the primary outcome
occurred in 21 patients assigned to preventive PCI and in 53 patients assigned
to no preventive PCI which means rates of 9 events per 100 patients and 23 per
100, respectively (hazard ratio in the preventive-PCI group, 0.35; P<0.001)
with hazard ratio 0.34 for death from cardiac causes, 0.32 for nonfatal
myocardial infarction, and 0.35 for refractory angina.
Authors then concluded that in patients undergoing emergency infarct-artery
PCI for acute STEMI, preventive PCI of stenoses in non culprit arteries reduced
the risk of subsequent adverse cardiovascular events, as compared with PCI limited
to the infarct artery.
writed at 19-10-2013 17:19:08